Status:
COMPLETED
Raynaud's Treatment Study (RTS)
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Heart Diseases
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
To determine the relative efficacy of usual medical care and a course of treatment by thermal biofeedback in reducing vasospastic attacks characteristic of Raynaud's syndrome. Also, to confirm the fre...
Detailed Description
BACKGROUND: Primary Raynaud's phenomenon is a peripheral vascular disorder resulting in vasospastic attacks provoked by cold and/or emotional stress. Attacks most often occur in the fingers, but may ...
Eligibility Criteria
Men and women with documented primary or secondary Raynaud's syndrome.
Key Trial Info
Start Date :
September 1 1992
Trial Type :
INTERVENTIONAL
End Date :
June 1 1998
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000530
Start Date
September 1 1992
End Date
June 1 1998
Last Update
April 15 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.